IDO siRNA (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemIDO siRNA (h)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-45939
Gene Nameindoleamine 2,3-dioxygenase 1
Quantity10 µM
Specieshuman
NCBI Full Gene Nameindoleamine 2,3-dioxygenase 1
NCBI Gene AliasesIDO, IDO-1, INDO
TypesiRNA/dsRNA

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunityImmunityOctober 12, 2021Sharma MD, Pacholczyk R, Shi H, Berrong ZJ, Zakharia Y, Greco A, Chang CS, Eathiraj S, Kennedy E, Cash T, et al.

(2) LPS enhances CTB-INSULIN induction of IDO1 and IL-10 synthesis in human dendritic cellsCellular immunologyApril 1, 2019Kim NS, Torrez T, Langridge W.(siRNA). To define CTB-INS-induced IDO1 expression in DCs, human IDO1-small interfering RNA (IDO1 siRNA, sc-45939) and non-targeting siRNA (Control siRNA Fluorescein conjugate, sc36869) were purchased from Santa Cruz Biotechnology

(3) Enhanced Immunosuppressive Properties of Human Mesenchymal Stem Cells Primed by Interferon-γEBioMedicineFebruary 1, 2018Kim DS, Jang IK, Lee MW, Ko YJ, Lee DH, Lee JW, Sung KW, Koo HH, Yoo KH.

(4) Identification of Interferon-Stimulated Gene Proteins That Inhibit Human Parainfluenza Virus Type 3Journal of virologyDecember 15, 2016Rabbani MA, Ribaudo M, Guo JT, Barik S.2,3-dioxygenase) and the complete transfection reagent system were from Santa Cruz Biotechnology (catalog numbers sc-45939 and sc-45064, respectively). The siRNA transfection was performed according to the manufacturer’s protocol.

(5) Human osteoclasts are inducible immunosuppressive cells in response to T cell-derived IFN-γ and CD40 ligand in vitroJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral ResearchDecember 1, 2014Li H, Lu Y, Qian J, Zheng Y, Zhang M, Bi E, He J, Liu Z, Xu J, Gao JY, et al.

(6) Mesenchymal stem cells: a double-edged sword in regulating immune responsesCell death and differentiationSeptember 1, 2012Li W, Ren G, Huang Y, Su J, Han Y, Li J, Chen X, Cao K, Chen Q, Shou P, et al.

(7) Superinduction of immunosuppressive glioblastoma extracellular vesicles by IFN-γ through PD-L1 and IDO1Neuro-oncology advancesJanuary 1, 0001Jung MY, Aibaidula A, Brown DA, Himes BT, Cumba Garcia LM, Parney IF.PD-L1 and IDO1 knockdown. Short interfering RNA (siRNA) sequences targeting PD-L1 (sc-39699), IDO1 (sc-45939), or a nontargeting siRNA control (sc-37007) were acquired (Santa Cruz Inc). Each siRNA product consisted

Be the First to Write a Review!

IDO siRNA (h)

IDO siRNA (h) from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (7)

Reviews

IDO siRNA (h) from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map